• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Cytokinetics (CYTK)

Common Shares
Sell: $62.01|Buy: $62.15|Change: 0.52 (0.84%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Address

280 East Grand Avenue
South San Francisco
CA
USA
94080

Telephone

+1 650 624-3000

Website

https://www.cytokinetics.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Cytokinetics Inc Third Quarter Earnings Conference Call for 20262026-11-05T16:30:00
Cytokinetics Inc Third Quarter Earnings Results for 20262026-11-05T16:00:00
Cytokinetics Inc Second Quarter Earnings Conference Call for 20262026-08-07T16:30:00
Cytokinetics Inc Second Quarter Earnings Results for 20262026-08-07T16:00:00
Cytokinetics Inc Annual General Meeting for 20262026-05-14T13:00:00
Cytokinetics Inc First Quarter Earnings Conference Call for 20262026-05-06T16:30:00
Cytokinetics Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Cytokinetics Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T16:30:00
Cytokinetics Inc Fourth Quarter Earnings Results for 20252026-02-27T16:00:00
Cytokinetics Inc Annual Report for 20252026-02-27T00:00:00

Previous key dates

NameKey Date
Jefferies Global Healthcare Conference2025-11-17T14:30:00
Stifel 2025 Healthcare Conference2025-11-11T11:20:00
Cytokinetics Inc Third Quarter Earnings Conference Call for 20252025-11-05T16:30:00
Cytokinetics Inc Third Quarter Earnings Results for 20252025-11-05T16:00:00
Stifel 2025 Virtual Cardiometabolic Forum2025-09-30T10:00:00
Citi’s 2025 BioPharma Back to School Conference2025-09-02T14:30:00
Primary results from MAPLE-HCM2025-09-02T08:30:00
Cytokinetics Inc Second Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Cytokinetics Inc Second Quarter Earnings Results for 20252025-08-07T16:00:00
Jefferies Global Healthcare Conference2025-06-04T09:20:00
Cytokinetics Inc Annual General Meeting for 20252025-05-14T13:00:00
Cytokinetics Inc First Quarter Earnings Conference Call for 20252025-05-06T16:30:00
Cytokinetics Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-07T14:15:00
Barclays 27th Annual Global Healthcare Conference2025-03-12T13:30:00
Leerink Global Biopharma Conference2025-03-10T11:20:00
Cytokinetics Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
Cytokinetics Inc Fourth Quarter Earnings Results for 20242025-02-27T16:00:00
Cytokinetics Inc Annual Report for 20242025-02-27T00:00:00
Oppenheimer 35th Annual Healthcare Life Sciences Conference2025-02-12T16:40:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T09:00:00
36th Annual Piper Sandler Healthcare Conference2024-12-04T08:00:00
7th Annual Evercore ISI HealthconX Conference2024-12-03T09:35:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.